Chugai Receives Orphan Drug Designation for TECENTRIQ® in Small cell Lung Cancer and for Entrectinib in NTRK Fusion-positive Solid Tumors
2018-12-06
Dear Investor,
Please find attached a press release by Chugai.
Do not hesitate to contact us for any further questions.
Investors
Investor updates
stay updated
get the latest news and updates to your inbox.